Shares of Momenta Pharmaceuticals Inc. MNTA, + 69.40% 69% shot to record highs in prime trade Wednesday, after biotechnology company announced agreement with Johnson & Johnson JNJ, + 0.63% in a deal valued at $ 6.5 billion. Under the terms of the deal, J&J will pay $ 52.50 for each …
Read More »The stock rockets from Momenta Pharmaceuticals after a $ 6.5 billion buyout with Johnson & Johnson
